Outcome of the Board Meeting Held on Thursday, November 6, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Patel Chem Specialities reported its first results since listing, for the half year ended September 30, 2025. Revenue from operations rose to ₹6,115.81 lakhs from ₹5,013.93 lakhs in H1 FY25, a growth of about 22%. Profit after tax came in at ₹612.92 lakhs versus ₹522.41 lakhs in the same period last year, up roughly 17%. Earnings per share stood at ₹3.03 for the half year, compared to ₹4.20 in H1 FY25 (lower per-share figure is due to the share base expanding after the IPO). The balance sheet shows a sharp jump in cash and bank balances to ₹3,998.92 lakhs (from ₹64.07 lakhs at March 31, 2025) and reserves at ₹6,819.30 lakhs, reflecting fresh equity raised. The auditor (Parikh Shah & Associates) issued an unmodified Limited Review opinion with no qualifications. The company also separately disclosed related party transactions, mainly purchases and sales of goods with group entities and group company Patelchem North America, plus director remuneration and unsecured loans.
Healthy top-line growth and improving profitability, combined with a clean audit review and a strengthened balance sheet post-IPO, are positive signals for shareholders. Shareholders should note material related party dealings with promoter-controlled entities, which warrant monitoring.